Dharmacon Pockets $5.7M in Series A Financing Round

Aug 26, 2002

NEW YORK, Aug. 26 - Synthetic RNA developer Dharmacon Research has secured $5.7 million in a Series A round of private-equity financing.

Boulder Ventures led the round, which included investments by Telegraph Hill Partners.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.